Department of Biomedical and Neuromotor Sciences (DIBINEM), Alma Mater Studiorum University of Bologna, Bologna, Italy.
Azienda Ospedaliero Universitaria Policlinico Modena, Modena, Italy.
Pathologica. 2022 Dec;114(6):410-421. doi: 10.32074/1591-951X-828.
The WHO 2021 classification of central nervous system cancers distinguishes diffuse gliomas that arise in adults (referred to as the "adult type") and those that arise in children (defined as "paediatric") based on clinical and molecular characteristics."). However, paediatric-type gliomas may occasionally be present in younger adults and occasionally adult-type gliomas may occur in children. Diffuse low-grade paediatric glioma includes diffuse astrocytoma altered by MYB or MYBL1, low-grade polymorphic juvenile neuroepithelial tumour, angiocentric glioma, and diffuse low-grade glioma with an altered MAPK pathway. Here, we examine these newly recognised entities according to WHO diagnostic criteria and propose an integrated diagnostic approach that can be used to separate these clinically and biologically distinct tumor groups.
世界卫生组织(WHO)2021 年中枢神经系统肿瘤分类根据临床和分子特征,将成人中发生的弥漫性神经胶质瘤(称为“成人型”)与儿童中发生的弥漫性神经胶质瘤(定义为“小儿型”)区分开来。然而,小儿型神经胶质瘤偶尔也可能出现在年轻的成年人中,而成年人型神经胶质瘤偶尔也可能出现在儿童中。弥漫性低级别小儿神经胶质瘤包括由 MYB 或 MYBL1 改变的弥漫性星形细胞瘤、低度多形性幼年性神经上皮肿瘤、血管中心性胶质瘤和具有改变的 MAPK 通路的弥漫性低级别神经胶质瘤。在这里,我们根据世界卫生组织的诊断标准检查这些新确认的实体,并提出一种综合诊断方法,可用于区分这些具有临床和生物学特征的肿瘤群体。